Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

The ICON and AGO Collaborators (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. The Lancet, 361 (9375). pp. 2099-2106. ISSN 0140-6736

Full text not available from this repository.
Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 24 Sep 2013 00:56
Last Modified: 03 Oct 2022 05:11
URI: https://ueaeprints.uea.ac.uk/id/eprint/43393
DOI: 10.1016/S0140-6736(03)13718-X

Actions (login required)

View Item View Item